Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2005.04.7076 on April 10 2006

Journal of Clinical Oncology, Vol 24, No 13 (May 1), 2006: pp. 2013-2018
© 2006 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum (v27,p653)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleiweiss, I. J.
Right arrow Articles by Jaffer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleiweiss, I. J.
Right arrow Articles by Jaffer, S.
Related Articles
Right arrowRelated Editorial
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Axillary Sentinel Lymph Nodes Can Be Falsely Positive Due to Iatrogenic Displacement and Transport of Benign Epithelial Cells in Patients With Breast Carcinoma

Ira J. Bleiweiss, Chandandeep S. Nagi, Shabnam Jaffer

From the Lillian and Henry Stratton/Hans Popper Department of Pathology, Mount Sinai School of Medicine, New York, NY

Address reprint requests to: Ira J. Bleiweiss, MD, Department of Pathology, Mount Sinai School of Medicine, Box 1194, 1 Gustave L. Levy Pl, New York, NY 10029; e-mail: i.bleiweiss{at}mountsinai.org

PURPOSE: Immunohistochemical (IHC) staining for cytokeratins (CK) is common practice in evaluating sentinel lymph nodes (SLNs) in patients with breast carcinoma. IHC positivity typically indicates metastasis. SLN procedures are increasingly common in patients with pure intraductal carcinoma (DCIS). Iatrogenic epithelial cell displacement and benign transport of breast epithelial cells into axillary lymph nodes are recently described phenomena. We report 25 cases in which these factors probably resulted in benign epithelial cells in axillary SLNs (ie, false positivity).

METHODS: We reviewed 25 cases of CK-positive SLNs in which the epithelial cells had histologic and IHC characteristics different from their respective patients’ underlying breast carcinomas.

RESULTS: In all cases, the cytologic features of the epithelial cells in the SLNs were benign, and 22 matched those of corresponding intraductal papillomas that were involved by or were separate from the DCIS in the original cores or surgical biopsies. Fifteen cases were pure DCIS; most invasive tumors were smaller than 1.0 cm. In six carcinomas (DCIS) showing strong Her-2/neu staining, the corresponding epithelial cells in the SLNs were negative. In 13 tumors that were strongly and uniformly positive for estrogen receptor (ER), the cytokeratin-positive cells in the SLNs were negative for ER. Nineteen cases showed benign epithelial cell displacement at the biopsy site.

CONCLUSION: Epithelial cells in SLNs may result from transport of displaced cells, usually originating in intraductal papillomas. Positive immunohistochemical results in SLNs should be interpreted with extreme caution to avoid automatically concluding that such cells represent metastasis. Sentinel lymph nodes in breast carcinoma can be falsely positive.

Presented in part at the 27th Annual San Antonio Breast Cancer Symposium, December 2004, and at the United States/Canadian Academy of Pathologists Annual Meeting, Vancouver, BC, March 2004. The study was approved by the institutional review board of the authors’ institution.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Editorial

  • Sentinel Lymph Node Histopathology in Breast Cancer: Minimal Disease Versus Artifact
    Beverley A. Carter and David L. Page
    JCO 2006 24: 1978-1979 [Full Text]


This article has been cited by other articles:


Home page
NEJMHome page
M. de Boer, C. H.M. van Deurzen, J. A.A.M. van Dijck, G. F. Borm, P. J. van Diest, E. M.M. Adang, J. W.R. Nortier, E. J.T. Rutgers, C. Seynaeve, M. B.E. Menke-Pluymers, et al.
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
N. Engl. J. Med., August 13, 2009; 361(7): 653 - 663.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Tamaki, F. Akiyama, T. Iwase, T. Kaneko, H. Tsuda, K. Sato, S. Ueda, M. Mano, N. Masuda, M. Takeda, et al.
Molecular Detection of Lymph Node Metastases in Breast Cancer Patients: Results of a Multicenter Trial Using the One-Step Nucleic Acid Amplification Assay
Clin. Cancer Res., April 15, 2009; 15(8): 2879 - 2884.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. B. Julian, P. Blumencranz, K. Deck, P. Whitworth, D. A. Berry, S. M. Berry, A. Rosenberg, A. B. Chagpar, D. Reintgen, P. Beitsch, et al.
Novel Intraoperative Molecular Test for Sentinel Lymph Node Metastases in Patients With Early-Stage Breast Cancer
J. Clin. Oncol., July 10, 2008; 26(20): 3338 - 3345.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. J.T. Rutgers
Sentinel Node Biopsy: Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With Micrometastases
J. Clin. Oncol., February 10, 2008; 26(5): 698 - 702.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. R. Turner, D. L. Weaver, G. Cserni, S. C. Lester, K. Hirsch, D. A. Elashoff, P. L. Fitzgibbons, G. Viale, G. Mazzarol, J. A. Ibarra, et al.
Nodal Stage Classification for Breast Carcinoma: Improving Interobserver Reproducibility Through Standardized Histologic Criteria and Image-Based Training
J. Clin. Oncol., January 10, 2008; 26(2): 258 - 263.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
A. M. Mulligan and F. P. O'Malley
Metastatic Potential of Encapsulated (Intracystic) Papillary Carcinoma of the Breast: A Report of 2 Cases With Axillary Lymph Node Micrometastases
International Journal of Surgical Pathology, April 1, 2007; 15(2): 143 - 147.
[Abstract] [PDF]


Home page
Endocr Relat CancerHome page
M. Lacroix
Significance, detection and markers of disseminated breast cancer cells
Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
N. Jonjic, E. Mustac, A. Dekanic, B. Marijic, B. Gaspar, I. Kolic, M. Coklo, and F. Sasso
Predicting Sentinel Lymph Node Metastases in Infiltrating Breast Carcinoma With Vascular Invasion
International Journal of Surgical Pathology, October 1, 2006; 14(4): 306 - 311.
[Abstract] [PDF]


Home page
JCOHome page
B. A. Carter and D. L. Page
Sentinel Lymph Node Histopathology in Breast Cancer: Minimal Disease Versus Artifact
J. Clin. Oncol., May 1, 2006; 24(13): 1978 - 1979.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online